Abstract
1.1. The fifteen-year incidence of toxemia and eclampsia at Maternity Hospital, University Hospitals of Cleveland, has been presented.2.2. The treatment of eclampsia with veratrum viride, magnesium sulfate, and hypertonic glucose has been outlined.3.3. Urea clearance studies on nine patients indicate that diminution following veratrum viride is slight and transient and returns to normal levels when combined with magnesium sulfate and hypertonic glucose.4.4. A comparison of mortality statistics at Maternity Hospital has been found to be 12.9 per cent before veratrum viride was included in the treatment of eclampsia and 2.9 per cent after its use was begun.5.5. It is suggested that the drug is especially valuable in that it makes it possible to control the eclamptic patient until delivery can be safely undertaken.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
